[go: up one dir, main page]

ES2057572T3 - Agentes de reconocimiento. - Google Patents

Agentes de reconocimiento.

Info

Publication number
ES2057572T3
ES2057572T3 ES90909466T ES90909466T ES2057572T3 ES 2057572 T3 ES2057572 T3 ES 2057572T3 ES 90909466 T ES90909466 T ES 90909466T ES 90909466 T ES90909466 T ES 90909466T ES 2057572 T3 ES2057572 T3 ES 2057572T3
Authority
ES
Spain
Prior art keywords
msh4
alpha
recognition agents
nle
dtpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90909466T
Other languages
English (en)
Inventor
David Peter Page-Thomas
David Roy Bard
Clive Graham Knight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898914527A external-priority patent/GB8914527D0/en
Priority claimed from GB909007469A external-priority patent/GB9007469D0/en
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Application granted granted Critical
Publication of ES2057572T3 publication Critical patent/ES2057572T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

DERIVADOS DEL (ALFA)-MSH SUB 4-10 POLIPEPTIDO ANALOGO [N1E ELEVADO 4, ASP ELEVADO 5, D-PHE ELEVADO 7, LYS ELEVADO 10] (ALFA)-MSH SUB 4-10-NH SUB 2 QUE PORTA UNA MITAD OBJETIVADA TALES COMO UN RADIONUCLEADO DIAGNOSTICO O TERAPEUTICO O UN GRUPO HETEROCICLICO TALES COMO DTPA SON UTILES EN LA DIAGNOSIS Y TRATAMIENTO DEL MELANOMA.
ES90909466T 1989-06-23 1990-06-22 Agentes de reconocimiento. Expired - Lifetime ES2057572T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898914527A GB8914527D0 (en) 1989-06-23 1989-06-23 Targetting agents
GB909007469A GB9007469D0 (en) 1990-04-03 1990-04-03 Targetting agents

Publications (1)

Publication Number Publication Date
ES2057572T3 true ES2057572T3 (es) 1994-10-16

Family

ID=26295539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90909466T Expired - Lifetime ES2057572T3 (es) 1989-06-23 1990-06-22 Agentes de reconocimiento.

Country Status (9)

Country Link
EP (1) EP0478631B1 (es)
JP (1) JPH04506343A (es)
AT (1) ATE110280T1 (es)
AU (1) AU636365B2 (es)
DE (1) DE69011861T2 (es)
DK (1) DK0478631T3 (es)
ES (1) ES2057572T3 (es)
NZ (1) NZ234173A (es)
WO (1) WO1991000111A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437487B1 (en) * 1988-10-04 1994-03-09 Cancer Research Campaign Technology Limited Targetting agents
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
EP0796113A2 (en) * 1994-11-17 1997-09-24 Amgen Inc. Stable n-terminally linked dtpa:protein compositions and methods
US5618513A (en) * 1995-06-07 1997-04-08 Mallinckrodt Medical, Inc. Method for preparing radiolabeled peptides
US7588571B2 (en) 2005-03-18 2009-09-15 Ron Anthon Olsen Adjustable splint for osteosynthesis with modular joint
US8262657B2 (en) 2007-08-16 2012-09-11 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means and convergent bone pins
US7717916B2 (en) 2007-08-16 2010-05-18 Nutek Orthopaedics, Inc. External fixation apparatus with adjustable pin clamping means
US8123747B2 (en) 2007-08-16 2012-02-28 Nutek Orthopaedics, Inc. Apparatus for external fixation of a fractured distal radius with angularly adjustable pin clamping means
WO2009089066A2 (en) * 2008-01-10 2009-07-16 Stc.Unm Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
KR100999044B1 (ko) 2008-03-26 2010-12-09 한국원자력연구원 킬레이트제 접합 α-ＭＳＨ 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물

Also Published As

Publication number Publication date
DE69011861D1 (de) 1994-09-29
JPH04506343A (ja) 1992-11-05
ATE110280T1 (de) 1994-09-15
AU5839190A (en) 1991-01-17
EP0478631B1 (en) 1994-08-24
DK0478631T3 (da) 1995-04-10
WO1991000111A1 (en) 1991-01-10
NZ234173A (en) 1993-10-26
EP0478631A1 (en) 1992-04-08
AU636365B2 (en) 1993-04-29
DE69011861T2 (de) 1995-02-16

Similar Documents

Publication Publication Date Title
ATE106898T1 (de) Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
DE3680924D1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DK0573551T3 (da) Serinrige peptidlinkere
DK0407122T3 (da) Hidtil ukendte modificerede PF4-præparater samt anvendelsesmetoder
DE68912302D1 (de) Härtendes material für medizinischen und dentalen gebrauch.
HK184896A (en) Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
FR2705558B1 (fr) Prothèse de reconstruction de hanche et l'appareil de pose.
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
ES2057572T3 (es) Agentes de reconocimiento.
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
HU902004D0 (en) New trombolitic preparations
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ATE169476T1 (de) Chirurgisches instrument
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
EP0988316A4 (en) DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO IRON OVERLOAD AND FERRITIVE CONDITIONS, METHODS AND COMPOSITIONS THEREOF
IL101675A (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 478631

Country of ref document: ES